Adalta Ltd (1AD) - Cash Flow Conversion Efficiency

Latest as of December 2025: 2.240x

Based on the latest financial reports, Adalta Ltd (1AD) has a cash flow conversion efficiency ratio of 2.240x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-489.87K ≈ $-346.61K USD) by net assets (AU$-218.66K ≈ $-154.71K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Adalta Ltd (1AD) net asset quality to measure how much of total assets are equity-financed.

Adalta Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adalta Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 1AD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Adalta Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adalta Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Marshalls PLC LSE:MSLH	-0.006x
BetterLife Pharma Inc F:NPAU	0.030x
Boutique Newcity Public Company Limited BK:BTNC	-0.009x
Eng Kah Corporation Bhd KLSE:7149	0.048x
Proodeftiki S.A. AT:PRD	-0.022x
5E ADVANCED MATERIALS CDI F:J9I0	-0.101x
Ferguson Plc LSE:FERG	0.132x
GoHealth Inc. NASDAQ:GOCO	4.664x

Annual Cash Flow Conversion Efficiency for Adalta Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adalta Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Adalta Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-598.24K ≈ $-423.30K	AU$-2.94 Million ≈ $-2.08 Million	4.909x	+289.49%
2024-06-30	AU$2.03 Million ≈ $1.44 Million	AU$-5.26 Million ≈ $-3.72 Million	-2.590x	+3.59%
2023-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-5.13 Million ≈ $-3.63 Million	-2.687x	-253.48%
2022-06-30	AU$5.38 Million ≈ $3.81 Million	AU$-4.09 Million ≈ $-2.89 Million	-0.760x	-1.52%
2021-06-30	AU$6.39 Million ≈ $4.52 Million	AU$-4.78 Million ≈ $-3.38 Million	-0.749x	+52.93%
2020-06-30	AU$3.70 Million ≈ $2.62 Million	AU$-5.89 Million ≈ $-4.17 Million	-1.591x	-104.89%
2019-06-30	AU$7.49 Million ≈ $5.30 Million	AU$-5.82 Million ≈ $-4.12 Million	-0.776x	+19.51%
2018-06-30	AU$4.07 Million ≈ $2.88 Million	AU$-3.93 Million ≈ $-2.78 Million	-0.965x	-100.48%
2017-06-30	AU$7.75 Million ≈ $5.48 Million	AU$-3.73 Million ≈ $-2.64 Million	-0.481x	-334.96%
2016-06-30	AU$10.62 Million ≈ $7.51 Million	AU$-1.17 Million ≈ $-830.93K	-0.111x	+94.35%
2015-06-30	AU$705.89K ≈ $499.46K	AU$-1.38 Million ≈ $-978.16K	-1.958x	+73.76%
2014-06-30	AU$172.82K ≈ $122.28K	AU$-1.29 Million ≈ $-912.79K	-7.465x	-219.41%
2013-06-30	AU$283.92K ≈ $200.89K	AU$-663.54K ≈ $-469.50K	-2.337x	--

About Adalta Ltd

AU:1AD Australia Biotechnology

Market Cap

$5.41 Million

AU$7.65 Million AUD

Market Cap Rank

#28394 Global

#1494 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37